Mereo BioPharma Group plc — All Filings
425 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
20-F
20-F/A
3
4
4/A
424B3
424B5
425
6-K
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DRS
DRS/A
EFFECT
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
PRE 14A
RW
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| PRE 14A | PRE 14A | 0001193125-26-127271 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-127253 | Mar 27, 2026 | Mar 26, 2026 |
| 10-K | 10-K | 0001193125-26-115226 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-115211 | Mar 19, 2026 | — |
| 4 | 4 | 0001193125-26-082830 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082831 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082826 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082835 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082818 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082820 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082838 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-082815 | Feb 27, 2026 | Feb 26, 2026 |
| 8-K | 8-K | 0001193125-26-054787 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001867472-26-000003 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001231919-26-000157 | Feb 13, 2026 | — |
| 4 | 4 | 0001193125-26-033753 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | 4 | 0001193125-26-033754 | Feb 2, 2026 | Feb 1, 2026 |
| S-8 | S-8 | 0001193125-26-033579 | Feb 2, 2026 | — |
| 4 | 4 | 0001193125-26-033751 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | 4 | 0001193125-26-033752 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | 4 | 0001193125-26-033749 | Feb 2, 2026 | Feb 1, 2026 |
| 8-K | 8-K | 0001193125-26-009829 | Jan 12, 2026 | — |
| SCHEDULE 13G | — | 0000935836-26-000022 | Jan 9, 2026 | — |
| SCHEDULE 13G | — | 0001404574-26-000002 | Jan 6, 2026 | — |
| 8-K | 8-K | 0001193125-25-332520 | Dec 29, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004855 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-274319 | Nov 10, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-274272 | Nov 10, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-021789 | Aug 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-106924 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-178489 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-094921 | Jul 10, 2025 | Jul 9, 2025 |
| SCHEDULE 13G | — | 0001415889-25-016764 | Jun 11, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002074 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-071485 | May 14, 2025 | May 13, 2025 |
| 8-K | 8-K | 0000950170-25-069811 | May 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069816 | May 13, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-002234 | May 12, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-051800 | Apr 8, 2025 | May 13, 2025 |
| ARS | ARS | 0000950170-25-051802 | Apr 8, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | — | 0001415889-25-010152 | Apr 4, 2025 | — |
| 8-K | 8-K | 0000950170-25-044783 | Mar 26, 2025 | — |
| 10-K | 10-K | 0000950170-25-044787 | Mar 26, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0000902664-25-000868 | Feb 12, 2025 | — |
| 4 | 4 | 0000950170-25-015418 | Feb 6, 2025 | Feb 5, 2025 |
| 4 | 4 | 0000950170-25-015428 | Feb 6, 2025 | Feb 5, 2025 |
| 4 | 4 | 0000950170-25-015419 | Feb 6, 2025 | Feb 5, 2025 |
| 4 | 4 | 0000950170-25-015433 | Feb 6, 2025 | Feb 5, 2025 |
| 4 | 4 | 0000950170-25-015423 | Feb 6, 2025 | Feb 5, 2025 |
| 4 | 4 | 0000950170-25-015426 | Feb 6, 2025 | Feb 5, 2025 |